Please login to the form below

Not currently logged in
Email:
Password:

cilastatin

This page shows the latest cilastatin news and features for those working in and with pharma, biotech and healthcare.

Merck preps regulatory filings for much-needed antibiotic combo

Merck preps regulatory filings for much-needed antibiotic combo

The regimen combines Merck’s imipenem/cilastatin duo - sold as Primaxin as a broad-spectrum antibiotic for decades - with a new beta lactamase inhibitor called relebactam that is designed to restore ... The pivotal phase III trial showed that

Latest news

  • Merck starts pivotal trials of new antibiotic combination Merck starts pivotal trials of new antibiotic combination

    plus cilastatin, another drug designed to tackle resistance. ... The trial showed adding relebactam treatment to imipenem/cilastatin was not inferior to imipenem/cilastatin plus placebo - an important initial finding which shows the beta lactamase

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics